s MadCAM-1 as an immunological marker in the «gut liver axis» at patients with chronic hepatitis C and excess body weight

QR Code

s MadCAM-1 as an immunological marker in the «gut liver axis» at patients with chronic hepatitis C and excess body weight

Background and aims: to estimate concentration of sMadCAM-1 in peripheral blood at patients with chronic hepatitis C with excess body weight.Materials and methods: The research included 88 patients (67 men, 21 women 41.4±3.2 years of age) with chronic hepatitis C (CHC) and excess body weight (the in...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. V. Zhdanov, A. V. Semenov, S. S. Karyakin, K. V. Kozlov, V. S. Sukachev, Yu. V. Ostankova, D. E. Valutite, E. B. Zueva, R. S. Sidorov, A. V. Saulevich, Yu. I. Bulan’kov, Yu. I. Lyashenko, K. S. Ivanov
Format:	Article
Language:	Russian
Published:	Journal Infectology 2019-05-01
Series:	Журнал инфектологии
Subjects:	hepatitis c excess body weight small intestinal bacterial overgrowth liver fibrosis liver steatosis mucosal addressin cell adhesion molecule -1
Online Access:	https://journal.niidi.ru/jofin/article/view/885
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liver steatosis in brain death donors
by: D. V. Voronov, et al.
Published: (2021-04-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Value of abdominal ultrasound study in the evaluation of the liver parenchyma in potential related donors of liver fragments
by: Yu. R. Kamalov, et al.
Published: (2018-08-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Modern ultrasonic methods of diagnostics of hepatic steatosis
by: A. S. Kuznetsova, et al.
Published: (2023-08-01)

The dynamic of psycho-emotional condition in patients with chronic HCV infection (F1-F3) treated with bicyclol
by: K. V. Kozlov, et al.
Published: (2025-03-01)

Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

The role of hepatic biopsy in liver graft evaluation during liver procurement
by: M. S. Novruzbekov, et al.
Published: (2016-12-01)

Predictors of hepatic steatosis in living liver donors
by: M. G. Minina, et al.
Published: (2022-12-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

Hepatoprotective Effects of Momordica dioica Against Acetaminophen-induced Liver Damage in Rats: An Experimental Study
by: Pushpalatha Tanneeru, et al.
Published: (2025-07-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

LIPID METABOLISM DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS C
by: L. I. Tkachenko, et al.
Published: (2015-12-01)

Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
by: Hisanori Muto, et al.
Published: (2025-05-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Multiparametric ultrasound liver examination in cardiological overweight patients: determining the cause of fibrosis and severity of steatosis
by: D. Yu. Shestakova, et al.
Published: (2025-02-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE
by: D. V. Blinov, et al.
Published: (2015-06-01)

HEPATIC SOD1 GENE EXPRESSION CHANGES IN THE NAFLD PATHOGENESIS IN OBESITY
by: A. A. Komar, et al.
Published: (2021-10-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
by: N. V. Mikhaylova, et al.
Published: (2019-07-01)

CORRECTION OF MICROCIRCULATORY DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
by: M. E. Statsenko, et al.
Published: (2016-12-01)

Liver damage in patients hospitalized with acute decompensated heart failure, depending on the degree of glucose metabolism disorder
by: V. V. Tolkacheva, et al.
Published: (2024-10-01)

Interplatform Agreement Between Liver Steatosis Analysis and Ultrasound-Guided Attenuation Parameter in the Evaluation of Hepatic Steatosis
by: Chen J, et al.
Published: (2025-07-01)

НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ БОЛЕЗНЬ ПЕЧЕНИ: ОТ ТЕОРИИ К ПРАКТИКЕ
by: П. В. Селивёрстов
Published: (2015-02-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale
by: K. V. Zhdanov, et al.
Published: (2021-01-01)

ASSOCIATION OF INTESTINAL BACTERIAL OVERGROWTH AND DISEASES OF HEPATOBIARY TRACT
by: Ya. M. Vakhrushev, et al.
Published: (2019-02-01)

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 MEASUREMENT IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE
by: O. M. Drapkina, et al.
Published: (2015-10-01)

Metabolic mechanism of hepatic steatosis affecting production performance of dairy cows during peak lactation
by: LIU Xiaoyi, et al.
Published: (2024-10-01)

Non-invasive diagnosis of fibrosis in patients with CHC and obesity
by: K. V. Zhdanov, et al.
Published: (2020-03-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Modern concept of bacterial complications at liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2010-12-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

A CLINICAL CASE OF DRUG HEPATITIS A WOMAN WHO IS PREGNANT WITH OBESITY
by: I. O. Makarov, et al.
Published: (2016-05-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)